BlackRock Institutional Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $73.2M | Buy |
1,953,854
+51,511
| +3% | +$1.93M | 0.01% | 1111 |
|
|
2016
Q3 | $129M | Sell |
1,902,343
-23,987
| -1% | -$1.63M | 0.02% | 748 |
|
|
2016
Q2 | $107M | Buy |
1,926,330
+149,671
| +8% | +$8.31M | 0.02% | 814 |
|
|
2016
Q1 | $112M | Buy |
1,776,659
+3,770
| +0.2% | +$237K | 0.02% | 781 |
|
|
2015
Q4 | $167M | Buy |
1,772,889
+11,275
| +0.6% | +$1.06M | 0.03% | 616 |
|
|
2015
Q3 | $142M | Buy |
1,761,614
+9,049
| +0.5% | +$727K | 0.02% | 663 |
|
|
2015
Q2 | $210M | Sell |
1,752,565
-6,769
| -0.4% | -$811K | 0.03% | 539 |
|
|
2015
Q1 | $184M | Buy |
1,759,334
+156,051
| +10% | +$16.3M | 0.03% | 610 |
|
|
2014
Q4 | $156M | Buy |
1,603,283
+9,813
| +0.6% | +$952K | 0.02% | 652 |
|
|
2014
Q3 | $124M | Buy |
1,593,470
+35,771
| +2% | +$2.79M | 0.02% | 725 |
|
|
2014
Q2 | $98.4M | Buy |
1,557,699
+37,106
| +2% | +$2.34M | 0.02% | 905 |
|
|
2014
Q1 | $102M | Buy |
1,520,593
+31,555
| +2% | +$2.12M | 0.02% | 863 |
|
|
2013
Q4 | $95.7M | Buy |
1,489,038
+809
| +0.1% | +$52K | 0.02% | 877 |
|
|
2013
Q3 | $95.3M | Buy |
1,488,229
+14,911
| +1% | +$954K | 0.02% | 818 |
|
|
2013
Q2 | $45.7M | Buy |
+1,473,318
| New | +$45.7M | 0.01% | 1214 |
|